{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:26:13Z","timestamp":1793042773454,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Youth Medical Innovation and Practice Research Program of Guangzhou","award":["2023QNYXZD005"],"award-info":[{"award-number":["2023QNYXZD005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Accurately assessing the prognosis of bladder cancer patients after radical cystectomy has important clinical and research implications. Current models, based on traditional statistical approaches and complex variables, have limited performance. We aimed to develop a machine learning (ML)-based prognostic model to predict 5-year cancer-specific mortality (CSM) in bladder cancer patients undergoing radical cystectomy, and compare its performance with current validated models.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Patients were selected from the Surveillance, Epidemiology, and End Results database and the First Affiliated Hospital of Sun Yat-sen University for model construction and validation. We used univariate and multivariate Cox regression to select variables with independent prognostic significance for inclusion in the model\u2019s construction. Six ML algorithms and Cox proportional hazards regression were used to construct prediction models. Concordance index (C-index) and Brier scores were used to compare the discrimination and calibration of these models. The Shapley additive explanation method was used to explain the best-performing model. Finally, we compared this model with three existing prognostic models in urothelial carcinoma patients using C-index, area under the receiver operating characteristic curve (AUC), Brier scores, calibration curves, and decision curve analysis (DCA).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>This study included 8,380 patients, with 6,656 in the training set, 1,664 in the internal validation set, and 60 in the external validation set. Eight features were ultimately identified to build models. The Light Gradient Boosting Machine (LightGBM) model showed the best performance in predicting 5-year CSM in bladder cancer patients undergoing radical cystectomy (internal validation: C-index\u2009=\u20090.723, Brier score\u2009=\u20090.191; external validation: C-index\u2009=\u20090.791, Brier score\u2009=\u20090.134). The lymph node density and tumor stage have the most significant impact on the prediction. In comparison with current validated models, our model also demonstrated the best discrimination and calibration (internal validation: C-index\u2009=\u20090.718, AUC\u2009=\u20090.779, Brier score\u2009=\u20090.191; external validation: C-index\u2009=\u20090.789, AUC\u2009=\u20090.884, Brier score\u2009=\u20090.137). Finally, calibration curves and DCA exhibited better predictive performance as well.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>We successfully developed an explainable ML model for predicting 5-year CSM after radical cystectomy in bladder cancer patients, and it demonstrated better performance compared to existing models.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12885-025-13942-2","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T20:52:05Z","timestamp":1742590325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Using machine learning for predicting cancer-specific mortality in bladder cancer patients undergoing radical cystectomy: a SEER-based study"],"prefix":"10.1186","volume":"25","author":[{"given":"Lei","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaosheng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"13942_CR1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71:209\u201349.","journal-title":"Cancer J Clin"},{"key":"13942_CR2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0302-2838(03)00416-0","volume":"44","author":"P Dahm","year":"2003","unstructured":"Dahm P, Gschwend JE. Malignant non-urothelial neoplasms of the urinary bladder: A review. Eur Urol. 2003;44:672\u201381.","journal-title":"Eur Urol"},{"key":"13942_CR3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk M, Burger M, Capoun O, Cohen D, Comp\u00e9rat EM, Dominguez Escrig JL, Gontero P, Liedberg F, Masson-Lecomte A, Mostafid AH, et al. European association of urology guidelines on non\u2013muscle-invasive bladder cancer (Ta, T1, and carcinoma in Situ). Eur Urol. 2022;81:75\u201394.","journal-title":"Eur Urol"},{"key":"13942_CR4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","volume":"85","author":"J Alfred Witjes","year":"2024","unstructured":"Alfred Witjes J, Max Bruins H, Carri\u00f3n A, Cathomas R, Comp\u00e9rat E, Efstathiou JA, Fietkau R, Gakis G, Lorch A, Martini A, et al. European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2023 guidelines. Eur Urol. 2024;85:17\u201331.","journal-title":"Eur Urol"},{"key":"13942_CR5","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1177\/03915603241240644","volume":"91","author":"FP Bizzarri","year":"2024","unstructured":"Bizzarri FP, Scarciglia E, Russo P, Marino F, Presutti S, Moosavi SK, Ragonese M, Campetella M, Gandi C, Totaro A, et al. Elderly and bladder cancer: the role of radical cystectomy and orthotopic urinary diversion. Urol J. 2024;91:500\u20134.","journal-title":"Urol J"},{"key":"13942_CR6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ajur.2020.06.002","volume":"7","author":"W Xie","year":"2020","unstructured":"Xie W, Bi J, Wei Q, Han P, Song D, Shi L, Ye D, Shen Y, Gou X, He W, et al. Survival after radical cystectomy for bladder cancer: multicenter comparison between minimally invasive and open approaches. Asian J Urol. 2020;7:291\u2013300.","journal-title":"Asian J Urol"},{"key":"13942_CR7","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.juro.2006.08.004","volume":"176","author":"SF Shariat","year":"2006","unstructured":"Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the bladder cancer research consortium. J Urol. 2006;176:2414\u201322.","journal-title":"J Urol"},{"key":"13942_CR8","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1200\/JCO.2005.05.3884","volume":"24","author":"Postoperative Nomogram Predicting","year":"2006","unstructured":"Postoperative Nomogram Predicting. Risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol. 2006;24:3967\u201372.","journal-title":"J Clin Oncol"},{"key":"13942_CR9","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1002\/cncr.30918","volume":"123","author":"CJ Welty","year":"2017","unstructured":"Welty CJ, Sanford TH, Wright JL, Carroll PR, Cooperberg MR, Meng MV, Porten SP. The cancer of the bladder risk assessment (COBRA) score: estimating mortality after radical cystectomy. Cancer. 2017;123:4574\u201382.","journal-title":"Cancer"},{"key":"13942_CR10","doi-asserted-by":"crossref","unstructured":"Sarri\u00f3-Sanz P, Martinez\u2010Cayuelas L, Lumbreras B, S\u00e1nchez\u2010Caballero L, Palaz\u00f3n\u2010Bru A, Gil\u2010Guill\u00e9n VF, G\u00f3mez\u2010P\u00e9rez L. Mortality prediction models after radical cystectomy for bladder tumour: a systematic review and critical appraisal. Eur J Clin Invest. 2022;52.","DOI":"10.1111\/eci.13822"},{"key":"13942_CR11","doi-asserted-by":"crossref","first-page":"9303","DOI":"10.1002\/cam4.3535","volume":"9","author":"Z Yang","year":"2020","unstructured":"Yang Z, Bai Y, Liu M, Hu X, Han P. Development and validation of a prognostic nomogram for predicting cancer-specific survival after radical cystectomy in patients with bladder cancer:a population\u2010based study. Cancer Med. 2020;9:9303\u201314.","journal-title":"Cancer Med"},{"key":"13942_CR12","doi-asserted-by":"crossref","first-page":"6663","DOI":"10.1158\/1078-0432.CCR-06-0372","volume":"12","author":"SF Shariat","year":"2006","unstructured":"Shariat SF, Karakiewicz PI, Palapattu GS, Amiel GE, Lotan Y, Rogers CG, Vazina A, Bastian PJ, Gupta A, Sagalowsky AI, et al. nomograms provide improved accuracy for predicting survival after radical cystectomy. Clin Cancer Res. 2006;12:6663\u201376.","journal-title":"Clin Cancer Res"},{"key":"13942_CR13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1001\/jama.2015.18421","volume":"315","author":"AM Darcy","year":"2016","unstructured":"Darcy AM, Louie AK, Roberts LW. Machine learning and the profession of medicine. JAMA. 2016;315:551\u20132.","journal-title":"JAMA"},{"key":"13942_CR14","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/s41591-023-02396-3","volume":"29","author":"SS Al-Zaiti","year":"2023","unstructured":"Al-Zaiti SS, Martin-Gill C, Z\u00e8gre-Hemsey JK, Bouzid Z, Faramand Z, Alrawashdeh MO, Gregg RE, Helman S, Riek NT, Kraevsky-Phillips K, et al. Machine learning for ECG diagnosis and risk stratification of occlusion myocardial infarction. Nat Med. 2023;29:1804\u201313.","journal-title":"Nat Med"},{"key":"13942_CR15","doi-asserted-by":"crossref","unstructured":"Hu J, Xu J, Li M, Jiang Z, Mao J, Feng L, Miao K, Li H, Chen J, Bai Z, et al. Identification and validation of an explainable prediction model of acute kidney injury with prognostic implications in critically ill children: a prospective multicenter cohort study. eClinicalMedicine. 2024;68.","DOI":"10.1016\/j.eclinm.2023.102409"},{"key":"13942_CR16","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1016\/S2589-7500(20)30314-9","volume":"3","author":"C Lee","year":"2021","unstructured":"Lee C, Light A, Alaa A, Thurtle D, van der Schaar M, Gnanapragasam VJ. Application of a novel machine learning framework for predicting non-metastatic prostate cancer-specific mortality in men using the surveillance, epidemiology, and end results (SEER) database. Lancet Digit Health. 2021;3:e158\u201365.","journal-title":"Lancet Digit Health"},{"key":"13942_CR17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/his.13734","volume":"74","author":"MJ Magers","year":"2018","unstructured":"Magers MJ, Lopez-Beltran A, Montironi R, Williamson SR, Kaimakliotis HZ, Cheng L. Staging of bladder cancer. Histopathology. 2018;74:112\u201334.","journal-title":"Histopathology"},{"key":"13942_CR18","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.eururo.2012.02.028","volume":"61","author":"RE Hautmann","year":"2012","unstructured":"Hautmann RE, de Petriconi RC, Pfeiffer C, Volkmer BG. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients. Eur Urol. 2012;61:1039\u201347.","journal-title":"Eur Urol"},{"key":"13942_CR19","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1200\/JCO.22.02762","volume":"41","author":"JP Stein","year":"2023","unstructured":"Stein JP, Lieskovsky G, Cote R, Groshen S, Feng A-C, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncology: Official J Am Soc Clin Oncol. 2023;41:3772\u201381.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"key":"13942_CR20","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.eururo.2015.06.053","volume":"69","author":"M Froehner","year":"2016","unstructured":"Froehner M, Koch R, Heberling U, Novotny V, Oehlschlaeger S, Hubler M, Baretton GB, Hakenberg OW, Wirth MP. Decreased overall and bladder cancer-specific mortality with adjuvant chemotherapy after radical cystectomy: multivariable competing risk analysis. Eur Urol. 2016;69:984\u20137.","journal-title":"Eur Urol"},{"key":"13942_CR21","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.eururo.2014.01.014","volume":"66","author":"G Gandaglia","year":"2014","unstructured":"Gandaglia G, Popa I, Abdollah F, Schiffmann J, Shariat SF, Briganti A, Montorsi F, Trinh QD, Karakiewicz PI, Sun M. The effect of neoadjuvant chemotherapy on perioperative outcomes in patients who have bladder cancer treated with radical cystectomy: a population-based study. Eur Urol. 2014;66:561\u20138.","journal-title":"Eur Urol"},{"key":"13942_CR22","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1464-410X.2012.10993.x","volume":"110","author":"JD Sammon","year":"2012","unstructured":"Sammon JD, Morgan M, Djahangirian O, Trinh QD, Sun M, Ghani KR, Jeong W, Jhaveri J, Ehlert M, Schmitges J, et al. Marital status: a gender-independent risk factor for poorer survival after radical cystectomy. BJU Int. 2012;110:1301\u20139.","journal-title":"BJU Int"},{"key":"13942_CR23","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s00345-018-2450-0","volume":"36","author":"F Soria","year":"2018","unstructured":"Soria F, Pisano F, Gontero P, Palou J, Joniau S, Serretta V, Larre S, Di Stasi S, van Rhijn B, Witjes JA, et al. Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy. World J Urol. 2018;36:1775\u201381.","journal-title":"World J Urol"},{"key":"13942_CR24","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1007\/s11255-012-0273-2","volume":"44","author":"HY Xie","year":"2012","unstructured":"Xie HY, Zhu Y, Yao XD, Zhang SL, Dai B, Zhang HL, Shen YJ, Wang CF, Zhang HZ, Ye DW. Development of a nomogram to predict non-organ-confined bladder urothelial cancer before radical cystectomy. Int Urol Nephrol. 2012;44:1711\u20139.","journal-title":"Int Urol Nephrol"},{"key":"13942_CR25","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1016\/j.ejso.2021.04.035","volume":"47","author":"C De Nunzio","year":"2021","unstructured":"De Nunzio C, Franco A, Simone G, Tuderti G, Anceschi U, Brassetti A, Daneshmand S, Miranda G, Desai MM, Gill I, et al. Validation of the COBRA nomogram for the prediction of cancer specific survival in patients treated with radical cystectomy for bladder cancer: an international wide cohort study. Eur J Surg Oncol. 2021;47:2646\u201350.","journal-title":"Eur J Surg Oncol"},{"key":"13942_CR26","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.urolonc.2019.03.006","volume":"37","author":"HS Kim","year":"2019","unstructured":"Kim HS, Kwak C, Kim HH, Ku JH. The cancer of the bladder risk assessment (COBRA) score for predicting cancer-specific survival after radical cystectomy for urothelial carcinoma of the bladder: external validation in a cohort of Korean patients. Urol Oncol. 2019;37:470\u20137.","journal-title":"Urol Oncol"},{"key":"13942_CR27","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/bju.15163","volume":"126","author":"T Muilwijk","year":"2020","unstructured":"Muilwijk T, Akand M, Soria F, Giordano A, Milenkovic U, Moris L, Gevaert T, Van Poppel H, Albersen M, Gontero P, Joniau S. The cancer of the bladder risk assessment (COBRA) score for estimating cancer-specific survival after radical cystectomy: external validation in a large bi\u2010institutional cohort. BJU Int. 2020;126:704\u201314.","journal-title":"BJU Int"},{"key":"13942_CR28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/bju.12484","volume":"114","author":"A Al-Daghmin","year":"2014","unstructured":"Al-Daghmin A, English S, Kauffman EC, Din R, Khan A, Syed JR, Sztorc J, Mehedint D, Sharif M, Shi Y, et al. External validation of preoperative and postoperative nomograms for prediction of cancer-specific survival, overall survival and recurrence after robot-assisted radical cystectomy for urothelial carcinoma of the bladder. BJU Int. 2014;114:253\u201360.","journal-title":"BJU Int"},{"key":"13942_CR29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.juro.2015.08.093","volume":"195","author":"M Brooks","year":"2016","unstructured":"Brooks M, Godoy G, Sun M, Shariat SF, Amiel GE, Lerner SP. External validation of bladder cancer predictive nomograms for recurrence, cancer-free survival and overall survival following radical cystectomy. J Urol. 2016;195:283\u20139.","journal-title":"J Urol"},{"key":"13942_CR30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.eururo.2011.07.066","volume":"61","author":"P Nuhn","year":"2012","unstructured":"Nuhn P, May M, Sun M, Fritsche HM, Brookman-May S, Buchner A, Bolenz C, Moritz R, Herrmann E, Burger M, et al. External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder. Eur Urol. 2012;61:58\u201364.","journal-title":"Eur Urol"},{"key":"13942_CR31","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1464-410X.2009.09138.x","volume":"106","author":"D Zaak","year":"2010","unstructured":"Zaak D, Burger M, Otto W, Bastian PJ, Denzinger S, Stief CG, Buchner H, Hartmann A, Wieland WF, Shariat SF, Fritsche HM. Predicting individual outcomes after radical cystectomy: an external validation of current nomograms. BJU Int. 2010;106:342\u20138.","journal-title":"BJU Int"},{"key":"13942_CR32","doi-asserted-by":"crossref","first-page":"e677","DOI":"10.1016\/S2589-7500(20)30200-4","volume":"2","author":"J Wilkinson","year":"2020","unstructured":"Wilkinson J, Arnold KF, Murray EJ, van Smeden M, Carr K, Sippy R, de Kamps M, Beam A, Konigorski S, Lippert C, et al. Time to reality check the promises of machine learning-powered precision medicine. Lancet Digit Health. 2020;2:e677\u201380.","journal-title":"Lancet Digit Health"},{"key":"13942_CR33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.euo.2022.07.007","volume":"6","author":"Z-E Khene","year":"2023","unstructured":"Khene Z-E, Bigot P, Doumerc N, Ouzaid I, Boissier R, Nouhaud F-X, Albiges L, Bernhard J-C, Ingels A, Borchiellini D, et al. Application of machine learning models to predict recurrence after surgical resection of nonmetastatic renal cell carcinoma. Eur Urol Oncol. 2023;6:323\u201330.","journal-title":"Eur Urol Oncol"},{"key":"13942_CR34","doi-asserted-by":"crossref","unstructured":"Bhambhvani HP, Zamora A, Shkolyar E, Prado K, Greenberg DR, Kasman AM, Liao J, Shah S, Srinivas S, Skinner EC, Shah JB. Development of robust artificial neural networks for prediction of 5-year survival in bladder cancer. Urol Oncol. 2021;39:193.e197-193.e112.","DOI":"10.1016\/j.urolonc.2020.05.009"},{"key":"13942_CR35","doi-asserted-by":"crossref","unstructured":"Eminaga O, Shkolyar E, Breil B, Semjonow A, Boegemann M, Xing L, Tinay I, Liao JC. Artificial intelligence-based prognostic model for urologic cancers: A SEER-based study. Cancers. 2022;14.","DOI":"10.3390\/cancers14133135"},{"key":"13942_CR36","doi-asserted-by":"crossref","unstructured":"Claps F, Biasatti A, Di Gianfrancesco L, Ongaro L, Giannarini G, Pavan N, Amodeo A, Simonato A, Crestani A, Cimadamore A, et al. The prognostic significance of histological subtypes in patients with muscle-invasive bladder cancer: an overview of the current literature. J Clin Med. 2024;13.","DOI":"10.3390\/jcm13154349"},{"key":"13942_CR37","doi-asserted-by":"crossref","unstructured":"Polo-Alonso E, Kuk C, Guruli G, Paul AK, Thalmann G, Kamat A, Solsona E, Thalmann G, Urdaneta AI, Zlotta AR, Mir MC. Trimodal therapy in muscle invasive bladder cancer management. Minerva Urol Nefrol. 2020;72.","DOI":"10.23736\/S0393-2249.20.04018-7"},{"key":"13942_CR38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/BLC-230086","volume":"10","author":"EJ van Gennep","year":"2024","unstructured":"van Gennep EJ, Claps F, Bostrom PJ, Shariat SF, Neuzillet Y, Zlotta AR, Trombetta C, Eckstein M, Mertens LS, Bussani R, et al. multi-center assessment of lymph-node density and nodal-stage to predict disease-specific survival in patients with bladder cancer treated by radical cystectomy. Bladder Cancer. 2024;10:119\u201332.","journal-title":"Bladder Cancer"},{"key":"13942_CR39","doi-asserted-by":"crossref","unstructured":"Marcq G, Afferi L, Neuzillet Y, Nykopp T, Voskuilen CS, Furrer MA, Kassouf W, Aziz A, Bajeot AS, Alvarez-Maestro M, et al. Oncological outcomes for patients harboring positive surgical margins following radical cystectomy for Muscle-Invasive bladder cancer: A retrospective multicentric study on behalf of the YAU urothelial group. Cancers. 2022;14.","DOI":"10.3390\/cancers14235740"},{"key":"13942_CR40","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1007\/s00345-021-03776-5","volume":"39","author":"F Claps","year":"2021","unstructured":"Claps F, van de Kamp MW, Mayr R, Bostrom PJ, Boormans JL, Eckstein M, Mertens LS, Boev\u00e9 ER, Neuzillet Y, Burger M, et al. Risk factors associated with positive surgical margins\u2019 location at radical cystectomy and their impact on bladder cancer survival. World J Urol. 2021;39:4363\u201371.","journal-title":"World J Urol"},{"key":"13942_CR41","doi-asserted-by":"crossref","unstructured":"Russo P, Bizzarri FP, Filomena GB, Marino F, Iacovelli R, Ciccarese C, Boccuto L, Ragonese M, Gavi F, Rossi F, et al. Relationship between loss of Y chromosome and urologic cancers: new future perspectives. Cancers. 2024;16.","DOI":"10.3390\/cancers16223766"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13942-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13942-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13942-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T20:52:35Z","timestamp":1742590355000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13942-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13942"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13942-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,21]]},"assertion":[{"value":"30 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study approved by the Ethics Committee of the First Affiliated Hospital of Sun Yat-sen University, received a waiver for informed consent due to the absence of personally identifiable patient information in the data used for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"523"}}